Publications

Delles C. Maternally Inherited Essential Hypertension: Adding Further Complexity to an Already Complex Condition. Am J Hypertens. 2022 Jan 5;35(1):16-18. doi: 10.1093/ajh/hpab133. PMID: 34427578; PMCID: PMC8730502. 

Ebert T, Tran N, Schurgers L, Stenvinkel P, Shiels PG. Ageing - Oxidative stress, PTMs and disease. Mol Aspects Med. 2022 Jun 8;86:101099. doi: 10.1016/j.mam.2022.101099. Epub ahead of print. PMID: 35689974.

Díaz Del Campo LS, Rodrigues-Díez R, Salaices M, Briones AM, García-Redondo AB. Specialized Pro-Resolving Lipid Mediators: New Therapeutic Approaches for Vascular Remodeling. Int J Mol Sci. 2022 Mar 25;23(7):3592. doi: 10.3390/ijms23073592. PMID: 35408952; PMCID: PMC8998739.

Dechend R, Delles C. Endothelin antagonists and the quest for a new therapeutic option in resistant hypertension. Lancet. 2022 Dec 3;400(10367):1900-1901. doi: 10.1016/S0140-6736(22)02181-X. Epub 2022 Nov 7. PMID: 36356630.

M. Sanz-Gómez, F.J. Manzano-Lista, E. Vega-Martín, D. González-Moreno, M. Alcalá, M. Gil-Ortega, B. Somoza, C. Pizzamiglio, L.M. Ruilope, I. Aránguez, P. Kolkhof, R. Kreutz, M.S. Fernández-Alfonso. Finerenone protects against progression of kidney and cardiovascular damage in a model of type 1 diabetes through modulation of proinflammatory and osteogenic factors. Biomedicine & Pharmacotherapy, Volume 168, 2023, 115661, ISSN 0753-3322.

Vega-Martín E, González-Moreno D, Sanz-Gómez M, Guzmán-Aguayo AK, Manzano-Lista FJ, Schulz A, Aránguez I, Kreutz R, Fernández-Alfonso MS. Upregulation in Inflammation and Collagen Expression in Perirenal but Not in Mesenteric Adipose Tissue from Diabetic Munich Wistar Frömter Rats. International Journal of Molecular Sciences. 2023; 24(23):17008. https://doi.org/10.3390/ijms242317008

Rodrigues-Diez R, Ballesteros-Martinez C, Moreno-Carriles RM, Nistal F, Díaz Del Campo LS, Cachofeiro V, Dalli J, García-Redondo AB, Redondo JM, Salaices M, Briones AM. Resolvin D2 prevents vascular remodeling, hypercontractility and endothelial dysfunction in obese hypertensive mice through modulation of vascular and proinflammatory factors. Biomed Pharmacother. 2024 May;174:116564. doi: 10.1016/j.biopha.2024.116564. Epub 2024 Apr 11. PMID: 38608525..

Díaz Del Campo LS, García-Redondo AB, Rodríguez C, Zaragoza C, Duro-Sánchez S, Palmas F, de Benito-Bueno A, Socuéllamos PG, Peraza DA, Rodrigues-Díez R, Valenzuela C, Dalli J, Salaices M, Briones AM. Resolvin D2 Attenuates Cardiovascular Damage in Angiotensin II-Induced Hypertension. Hypertension. 2023 Jan;80(1):84-96. doi: 10.1161/HYPERTENSIONAHA.122.19448. Epub 2022 Nov 7. PMID: 36337053.